Nanogen Gets More Time for Nasdaq Compliance | GenomeWeb

NEW YORK (GenomeWeb News) – Nanogen said in a filing with the US Securities and Exchange Commission today that it now has until May 27 to regain compliance with Nasdaq's $1 minimum bid price listing requirement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.